• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 GA-CG-SVM 方法建立的乳腺癌耐药蛋白(BCRP)底物和非底物的预测模型。

A prediction model of substrates and non-substrates of breast cancer resistance protein (BCRP) developed by GA-CG-SVM method.

机构信息

State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, PR China.

出版信息

Comput Biol Med. 2011 Nov;41(11):1006-13. doi: 10.1016/j.compbiomed.2011.08.009. Epub 2011 Sep 14.

DOI:10.1016/j.compbiomed.2011.08.009
PMID:21924412
Abstract

Breast cancer resistance protein (BCRP) is one of the key multi-drug resistance proteins, which significantly influences the therapeutic effects of many drugs, particularly anti-cancer drugs. Thus, distinguishing between substrates and non-substrates of BCRP is important not only for clinical use but also for drug discovery and development. In this study, a prediction model of the substrates and non-substrates of BCRP was developed using a modified support vector machine (SVM) method, namely GA-CG-SVM. The overall prediction accuracy of the established GA-CG-SVM model is 91.3% for the training set and 85.0% for an independent validation set. For comparison, two other machine learning methods, namely, C4.5 DT and k-NN, were also adopted to build prediction models. The results show that the GA-CG-SVM model is significantly superior to C4.5 DT and k-NN models in terms of the prediction accuracy. To sum up, the prediction model of BCRP substrates and non-substrates generated by the GA-CG-SVM method is sufficiently good and could be used as a screening tool for identifying the substrates and non-substrates of BCRP.

摘要

乳腺癌耐药蛋白(BCRP)是一种主要的多药耐药蛋白,它显著影响许多药物的治疗效果,特别是抗癌药物。因此,区分 BCRP 的底物和非底物不仅对临床应用很重要,对药物发现和开发也很重要。在这项研究中,我们使用改进的支持向量机(SVM)方法,即 GA-CG-SVM,建立了 BCRP 底物和非底物的预测模型。所建立的 GA-CG-SVM 模型对训练集的总体预测准确率为 91.3%,对独立验证集的总体预测准确率为 85.0%。为了进行比较,我们还采用了两种其他的机器学习方法,即 C4.5 DT 和 k-NN,来建立预测模型。结果表明,与 C4.5 DT 和 k-NN 模型相比,GA-CG-SVM 模型在预测准确性方面具有显著优势。总之,GA-CG-SVM 方法生成的 BCRP 底物和非底物预测模型足够好,可以用作识别 BCRP 底物和非底物的筛选工具。

相似文献

1
A prediction model of substrates and non-substrates of breast cancer resistance protein (BCRP) developed by GA-CG-SVM method.基于 GA-CG-SVM 方法建立的乳腺癌耐药蛋白(BCRP)底物和非底物的预测模型。
Comput Biol Med. 2011 Nov;41(11):1006-13. doi: 10.1016/j.compbiomed.2011.08.009. Epub 2011 Sep 14.
2
Predicting substrates of the human breast cancer resistance protein using a support vector machine method.运用支持向量机方法预测人类乳腺癌耐药蛋白的底物。
BMC Bioinformatics. 2013 Apr 15;14:130. doi: 10.1186/1471-2105-14-130.
3
Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein.用于预测药物与P-糖蛋白和乳腺癌耐药蛋白相互作用的计算分类模型。
SAR QSAR Environ Res. 2014;25(12):939-66. doi: 10.1080/1062936X.2014.976265. Epub 2014 Dec 1.
4
Marine natural products as breast cancer resistance protein inhibitors.海洋天然产物作为乳腺癌耐药蛋白抑制剂
Mar Drugs. 2015 Apr 3;13(4):2010-29. doi: 10.3390/md13042010.
5
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).由乳腺癌耐药蛋白BCRP(ABCG2)介导的多药耐药。
Oncogene. 2003 Oct 20;22(47):7340-58. doi: 10.1038/sj.onc.1206938.
6
Determinants of the activity and substrate recognition of breast cancer resistance protein (ABCG2).乳腺癌耐药蛋白(ABCG2)活性及底物识别的决定因素。
Drug Metab Rev. 2014 Nov;46(4):459-74. doi: 10.3109/03602532.2014.942037. Epub 2014 Jul 18.
7
Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability.乳腺癌耐药蛋白(BCRP)作为主动外排转运体在血脑屏障(BBB)通透性方面的作用。
Mol Divers. 2015 Feb;19(1):163-72. doi: 10.1007/s11030-014-9562-2. Epub 2014 Dec 14.
8
Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.吉非替尼(“易瑞沙”,ZD1839),一种表皮生长因子受体酪氨酸激酶抑制剂,可逆转乳腺癌耐药蛋白/ABCG2介导的耐药性。
Cancer Res. 2005 Feb 15;65(4):1541-6. doi: 10.1158/0008-5472.CAN-03-2417.
9
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).黄酮类化合物作为乳腺癌耐药蛋白(BCRP)抑制剂的构效关系。
Bioorg Med Chem. 2011 Mar 15;19(6):2090-102. doi: 10.1016/j.bmc.2010.12.043. Epub 2010 Dec 30.
10
Classification of Breast Cancer Resistant Protein (BCRP) Inhibitors and Non-Inhibitors Using Machine Learning Approaches.使用机器学习方法对乳腺癌耐药蛋白(BCRP)抑制剂和非抑制剂进行分类
Comb Chem High Throughput Screen. 2015;18(5):476-85. doi: 10.2174/1386207318666150525094503.

引用本文的文献

1
Artificial intelligence and anti-cancer drugs' response.人工智能与抗癌药物的反应。
Acta Pharm Sin B. 2025 Jul;15(7):3355-3371. doi: 10.1016/j.apsb.2025.05.009. Epub 2025 May 21.
2
Ensemble Machine Learning Approaches Based on Molecular Descriptors and Graph Convolutional Networks for Predicting the Efflux Activities of MDR1 and BCRP Transporters.基于分子描述符和图卷积网络的集成机器学习方法用于预测 MDR1 和 BCRP 转运蛋白的外排活性。
AAPS J. 2023 Sep 12;25(5):88. doi: 10.1208/s12248-023-00853-y.
3
Direct Comparison of the Prediction of the Unbound Brain-to-Plasma Partitioning Utilizing Machine Learning Approach and Mechanistic Neuropharmacokinetic Model.
直接比较利用机器学习方法和机制神经药代动力学模型预测未结合的脑-血浆分配。
AAPS J. 2021 May 18;23(4):72. doi: 10.1208/s12248-021-00604-x.
4
STS-NLSP: A Network-Based Label Space Partition Method for Predicting the Specificity of Membrane Transporter Substrates Using a Hybrid Feature of Structural and Semantic Similarity.STS-NLSP:一种基于网络的标签空间划分方法,用于利用结构和语义相似性的混合特征预测膜转运体底物的特异性
Front Bioeng Biotechnol. 2019 Nov 6;7:306. doi: 10.3389/fbioe.2019.00306. eCollection 2019.
5
Role of breast cancer resistance protein (BCRP) as active efflux transporter on blood-brain barrier (BBB) permeability.乳腺癌耐药蛋白(BCRP)作为主动外排转运体在血脑屏障(BBB)通透性方面的作用。
Mol Divers. 2015 Feb;19(1):163-72. doi: 10.1007/s11030-014-9562-2. Epub 2014 Dec 14.
6
Development of conformation independent computational models for the early recognition of breast cancer resistance protein substrates.开发构象非依赖型计算模型以早期识别乳腺癌耐药蛋白底物。
Biomed Res Int. 2013;2013:863592. doi: 10.1155/2013/863592. Epub 2013 Aug 1.
7
Predicting substrates of the human breast cancer resistance protein using a support vector machine method.运用支持向量机方法预测人类乳腺癌耐药蛋白的底物。
BMC Bioinformatics. 2013 Apr 15;14:130. doi: 10.1186/1471-2105-14-130.